Stem Cells Not Rejected

Researchers uncover more evidence that reprogrammed stem cells are not attacked by the immune system, suggesting they may one day serve as effective therapies.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, NISSIM BENVENISTYResearchers have coaxed induced pluripotent stem cells (iPSCs) derived from mice to become several different cell lines and transplanted those cells into genetically identical mice without triggering a strong immune response.

The study, published this week (January 24) in Cell Stem Cell, comes hot on the heels of similar findings reported earlier this month, strengthening the case that cells generated from iPSCs could eventually be used for cell replacement therapy to treat various human diseases.

Because iPSCs can be derived from a patient’s own tissues, researchers believed that transplantation into that patient should not provoke an immune response. But in 2011, Yang Xu’s team at the University of California, Sand Diego, called such assumptions into question when they provided evidence that iPSCs derived from mice were attacked and rejected by the immune system when implanted into genetically identical mice.

This prompted Ashleigh Boyd and colleagues at Boston University Medical School to try a similar experiment themselves. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems